Instituto Hermes Pardini S.A

Short Term Long Term Short Term Comparison Long Term Comparison
  • PARD3
  • 1d0.00%
  • 1w0.00%
  • 1m1.75%
  • 1y16.67%
ATH
  • ATH Price$27.37
  • ATH Date2020-01-28
  • % since ATH-25.66%
  • % to ATH34.52%
ATL
  • ATL Price$11.68
  • ATL Date2018-09-14
  • % from ATL74.27%
  • Last Low Price$12.5509
  • Last Low Date2020-03-24
  • % From Last Low62.14%
IPO
  • IPO Price$20.52
  • % Current ROI USD-0.83%
  • ATH Price$27.37
  • % ROI ATH 23,442.78%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="PARD3"]

Key Data [addtoany]

Current price $20.35
Sector Healthcare
Industry Diagnostics & Research
Today's High/Low $20.35/$19.66
Volume 0.00
Previous Close $20.35
52 Week High/Low $21.8931/$14.5499
Market Cap 2,568,489,728.00
P/E Ratio 14.6739
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $1.5
Annualized Dividend $0.0262
$20.35
[addtoany]

Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil.
It offers clinical analysis tests, diagnostic imaging, vaccines, check-ups, and other diagnostic services through 124 centers in the states of Minas Gerais, Goiás, São Paulo, and Rio de Janeiro.
The company also provides lab-to-lab services, such as specialized tests for other laboratories, as well as consulting, training, and support services for its customers.
It primarily operates through eight brands, which include Hermes Pardini, Progenética, Diagnóstika, Biocod, DLE, Labfar, Toxicologia Pardini, and Solução.
The company serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is headquartered in Belo Horizonte, Brazil.

Annual Data | Millions of US $ except per share data 2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Cash on hand --------
Receivables $190.73$153.37$158.18$133.30$136.38$111.29$120.07$97.81
Inventory $28.15$28.77$27.04$20.31$18.45$17.78$27.52$19.34
Pre-Paid Expenses --------
Other Current Assets $22.21$20.98$35.39$31.07$14.11$16.15$8.97$4.70
Total Current Assets $516.75$489.78$479.15$385.70$361.62$312.38--
Property, Plant, And Equipment $497.13$235.92$229.43$226.06$208.25$190.29$184.75$150.21
Long-Term Investments -$0.49$0.46$0.55$0.36$0.24--
Goodwill And Intangible Assets $477.05$391.80$311.55$240.37$111.83$118.46$118.23$27.58
Other Long-Term Assets $69.56$66.64$80.74$125.32$87.64$54.83$54.36$56.53
Total Long-Term Assets $1,109.04$755.86$673.48$630.88----
Total Assets $1,625.79$1,245.64$1,152.63$1,016.58$797.29$708.14$613.93$459.22
Total Current Liabilities $333.75$235.44$239.39$373.88$186.86$164.23$135.85$104.93
Long Term Debt $220.06$228.48$237.07$76.91$107.61$99.91$79.49$17.67
Other Non-Current Liabilities $168.11$174.90$130.08$157.60$85.74$82.34$99.53$80.75
Total Long Term Liabilities $595.59$403.38$375.64$235.46----
Total Liabilities $929.34$638.82$615.03$609.35$380.21$350.02$319.44$206.54
Common Stock Net $336.07$336.07$336.07$148.80$148.80$148.80$148.80$148.80
Retained Earnings (Accumulated Deficit) $363.84$268.42$183.73$221.47$209.46$148.16$81.27$38.97
Comprehensive Income --------
Other Share Holders Equity $14.51$20.33$18.64$35.71$56.17$57.23--
Share Holder Equity $695.23$605.62$536.33$405.98$414.43$354.20$290.93$250.43
Total Liabilities And Share Holders Equity --------